First COVID-19 patient in Texas enrolled in UTHealth stem cell therapy study at Memorial Hermann

April 23, 2020

Bella Patel

The first COVID-19 patient in Texas has been enrolled in a stem cell therapy clinical trial for acute respiratory distress syndrome (ARDS) at The University of Texas Health Science Center at Houston (UTHealth).

The procedure took place April 16, 2020, at Memorial Hermann-Texas Medical Center.

ARDS is a serious condition of the lungs, in which they fill up with fluid and cannot supply the oxygen needed for organs throughout the body. In severe cases, patients with COVID-19 have developed ARDS, which requires a patient being placed on a ventilator.

Read the full story…

Written by: Deborah Mann Lake | April 17, 2020